Tekla Capital Management LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 180 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2023$3,046,273
+2.7%
67,7100.0%0.12%
+3.6%
Q4 2022$2,966,375
-47.2%
67,710
-39.1%
0.11%
-49.3%
Q2 2022$5,613,000
-9.7%
111,118
+14.3%
0.22%
+1.4%
Q1 2022$6,213,000
-42.4%
97,253
-20.7%
0.22%
-37.9%
Q2 2021$10,793,000
-9.5%
122,6990.0%0.35%
-14.4%
Q1 2021$11,930,000
-13.3%
122,6990.0%0.41%
-15.3%
Q4 2020$13,761,000
-12.7%
122,699
-27.8%
0.48%
-18.1%
Q3 2020$15,761,000
+70.9%
170,018
+43.8%
0.59%
+68.4%
Q2 2020$9,224,000
+13.2%
118,256
-15.1%
0.35%
-4.6%
Q1 2020$8,148,000
-13.0%
139,336
+19.2%
0.37%
+4.0%
Q4 2019$9,367,000
+26.3%
116,925
+15.9%
0.35%
+9.6%
Q3 2019$7,414,000
-17.2%
100,916
+6.3%
0.32%
-11.7%
Q2 2019$8,959,000
-3.3%
94,976
-17.9%
0.37%
-2.7%
Q1 2019$9,263,000
+37.2%
115,720
-7.6%
0.38%
+30.1%
Q4 2018$6,750,000
-40.8%
125,207
-14.2%
0.29%
-30.0%
Q3 2018$11,397,000
+23.0%
146,0010.0%0.41%
+17.3%
Q2 2018$9,268,000
+36.2%
146,001
+96.7%
0.35%
+32.8%
Q1 2018$6,806,00074,2210.26%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2018
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders